Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CanniMed financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Revenue
$16.7 M
FY, 2017
CreditSafe Score
?
Score changed on Apr 19, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|
| Revenue | 11.4M | 6.7M | 5.8M | 9.8M | 16.7M |
| Revenue growth, % | -41.1% | -14.2% | 69.3% | 70.3% | |
| Cost of goods sold | 3.9M | 1.2M | 132.0K | 1.6M | 5.5M |
| Gross profit | 7.5M | 5.5M | 5.7M | 8.2M | 11.2M |
| Gross profit margin, % | 65.6% | 82.1% | 97.7% | 84.2% | 66.9% |
| General and administrative expense | 2.3M | 3.0M | 2.0M | 3.6M | 5.4M |
| Operating expense total | 3.8M | 7.0M | 8.5M | 9.5M | 16.5M |
| Depreciation and amortization | 669.0K | 1.2M | 1.4M | 832.0K | 939.0K |
| EBIT | 3.7M | (1.5M) | (2.9M) | (9.5M) | (6.3M) |
| EBIT margin, % | 32.5% | -22.3% | -49.6% | -96.8% | -37.7% |
| Interest income | 137.0K | 82.0K | 18.0K | 2.0K | 418.0K |
| Interest expense | 111.0K | 364.0K | 846.0K | 1.5M | 1.6M |
| Pre tax profit | 3.7M | (1.8M) | (3.4M) | (10.4M) | (6.3M) |
| Income tax expense | 997.0K | (320.0K) | (483.0K) | (471.0K) | (386.0K) |
| Net Income | 2.7M | (1.5M) | (2.9M) | (22.8M) | (5.9M) |
| EPS | (6.2) | (0.3) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |